DSS Document Security Systems Inc.

Document Security Systems, Inc. Announces Location Change of Special Meeting of Stockholders To Be Held On May 4, 2020

Document Security Systems, Inc. Announces Location Change of Special Meeting of Stockholders To Be Held On May 4, 2020

ROCHESTER, N.Y., April 17, 2020 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (DSS or the “Company”) (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technologies today announced notice of a change in location of its Special Meeting of Stockholders to be held on Monday, May 4, 2020 at 9:00 a.m. Central Time (the “Special Meeting”). Due to the rapidly evolving public health concerns relating to the coronavirus, or COVID-19, and the closure of the original venue for the Special Meeting, the location of Special Meeting has been changed to 32731 Egypt Lane, Suite 602, Magnolia, Texas  77354.

The purpose of the Special Meeting is to consider and vote on certain a proposal relating to an amendment to the Company’s certificate of incorporation to effect a reverse split of its common stock by a ratio of 1-for-30 (the “Reverse Split”) and on such other business as may properly come before the Special Meeting or any adjournment thereof.  Further information regarding the change of location of the Special Meeting can be found in the Notice of Change of Location of Special Meeting of Stockholders filed by DSS with the Securities and Exchange Commission on April 17, 2020.

As described in the proxy statement for the Special Meeting previously distributed, DSS shareholders are entitled to participate in and vote at the Special Meeting if they were a shareholder of record as of the close of business on April 3, 2020, or hold an appropriate legal proxy for the meeting provided by their broker, bank or other nominee. Whether or not a shareholder plans to attend the Special Meeting, DSS urges its shareholders to vote and submit their proxy in advance of the Special Meeting by one of the methods described in the proxy statement. The proxy card included with the proxy statement previously distributed will not be updated to reflect the information provided above and may continue to be used to vote your shares in connection with the Special Meeting. If you have previously submitted a proxy using one of the methods described in the proxy statement and proxy card, you vote will be counted and you do not need to submit a new proxy or vote at the Special Meeting, although you may change or revoke your vote by attending the Special Meeting or by one of the other methods described in the proxy statement.

DSS shareholders who have questions about the proxy statement tor voting their shares should contact The Proxy Advisory Group, LLC, which is assisting with the solicitation of proxies, at:

The Proxy Advisory Group, LLC

18 East 41st Street, Suite 2000

New York, New York 10017

1-212-616-2180

About Document Security Systems, Inc. (DSS)

For over 15 years, DSS has protected corporations, financial institutions, and governments from sophisticated and costly fraud. DSS' innovative anti-counterfeit, authentication, and brand protection solutions are deployed to prevent attacks which threaten products, digital presence, financial instruments, and identification. AuthentiGuard®, the company's flagship product, provides authentication capability through a smartphone application so businesses can empower a wide range of employees, supply chain personnel, and consumers to track their brands and verify authenticity. For more information on DSS visit .

Contact Information:

Investor Inquiries:



Bret Shapiro

CoreIR

516 222 2560 

EN
17/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Document Security Systems Inc.

 PRESS RELEASE

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Me...

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that its subsidiary, Impact BioMedical Inc. (“Impact”), has entered into a definitive merger agreement (the “Merger Agreement”) with Dr. Ashleys Limited (“Dr. Ashleys”), a global pharmaceutical company. Under the terms of the agreement, Dr. Ashleys will acquire Impact through...

 PRESS RELEASE

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the St...

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters. In a quarter focused on streamlining operations and financial discipline, DSS delivered significan...

 PRESS RELEASE

Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FI...

Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. (“Sentinel”), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE American: DSS), is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to act as an underwriter and selling group member for corporate securities offerings. This regulatory milestone significantly enhances Sentinel’...

 PRESS RELEASE

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining...

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE American: IBO) in a strategic, all-equity transaction valued at approximately $1.15 million. This divestiture aligns with DSS’ ongoing strategy to optimize its portfolio and concentrate on core growth areas. Celios® is a cutting-edge air purifi...

 PRESS RELEASE

DSS, Inc. Issues Letter to Shareholders

DSS, Inc. Issues Letter to Shareholders NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued the following letter to shareholders: Dear Esteemed Shareholders, I am pleased to provide you with significant updates regarding the leadership of DSS, Inc. and to outline the strategic direction we are pursuing as a Company. It is with great honor that I announce my appointment as Interim Chief Executive...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch